↓ Skip to main content

MCM2 - a promising marker for premalignant lesions of the lung: a cohort study

Overview of attention for article published in BMC Cancer, June 2001
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MCM2 - a promising marker for premalignant lesions of the lung: a cohort study
Published in
BMC Cancer, June 2001
DOI 10.1186/1471-2407-1-6
Pubmed ID
Authors

Dong-Feng Tan, Joel A Huberman, Andrew Hyland, Gregory M Loewen, John SJ Brooks, Amy F Beck, Ivan T Todorov, Gerold Bepler

Abstract

Because cells progressing to cancer must proliferate, marker proteins specific to proliferating cells may permit detection of premalignant lesions. Here we compared the sensitivities of a classic proliferation marker, Ki-67, with a new proliferation marker, MCM2, in 41 bronchial biopsy specimens representing normal mucosa, metaplasia, dysplasia, and carcinoma in situ.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 3%
Unknown 37 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 18%
Student > Ph. D. Student 6 16%
Student > Postgraduate 6 16%
Student > Bachelor 3 8%
Student > Doctoral Student 2 5%
Other 8 21%
Unknown 6 16%
Readers by discipline Count As %
Medicine and Dentistry 12 32%
Agricultural and Biological Sciences 9 24%
Biochemistry, Genetics and Molecular Biology 6 16%
Neuroscience 2 5%
Computer Science 1 3%
Other 0 0%
Unknown 8 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2021.
All research outputs
#7,454,066
of 22,788,370 outputs
Outputs from BMC Cancer
#2,059
of 8,290 outputs
Outputs of similar age
#12,832
of 38,921 outputs
Outputs of similar age from BMC Cancer
#1
of 3 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,290 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 38,921 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them